Annovis Bio, Inc. (NYSE: ANVS) announced its financial results for the third quarter ending September 30, 2024, alongside ...

An anti-Alzheimer's nasal spray that could delay the progress of the disease by years has been developed by scientists at ...

Such an "exercise-in-a-pill" treatment could benefit older people, who may have trouble achieving recommended levels of ...

Panax ginseng shows highest effectiveness in treating Alzheimer's. Learn more about AVXL's blarcamesine and SAVA's simufilam ...

Ann Lange was diagnosed with Alzheimer's in 2015, but with the help of clinical trials her disease has not progressed past ...

We asked Dr. Joanne Pike, CEO of the Alzheimer's Association to help explain the challenges and hopes when it comes to this debilitating disease.

There is a lot of outrage that the new Alzheimer’s drug donanemab is being refused on the NHS. But there are good reasons for ...

An 80-something patient came in for an annual visit recently and was worried that recent memory lapses might be symptoms of ...

With Eisai and Biogen’s Leqembi and Eli Lilly’s Kisunla launching onto the market, the 2024 Clinical Trials of Alzheimer’s ...

The Alzheimer's Association hosted a Women's AWARE luncheon in Tulsa, raising awareness and funds for research.

Recent research has revealed that alcohol use disorder and Alzheimer’s disease share significant patterns of gene ...

A 72-year-old man from Youngstown, Ohio, has now completed a more than 2,200 mile fundraising bike ride across the country to ...